A recap of ACOG's 75th Annual Clinical & Scientific Meeting

From May 1-3, 2026, the Contemporary OB/GYN editorial team was on location in Washington, DC, to highlight the latest clinical developments out of the 2026 American College of Obstetricians & Gynecologists (ACOG) Annual Clinical & Scientific Meeting.¹

We spoke directly with over 25 experts in women’s health in various capacities, from discussions on how patients have welcomed elinzanetant to the lack of data associated with preeclampsia and eclampsia in Black women with endometriosis.

In a meeting that saw Camille A. Clare, MD, MPH, CPE, FACOG, of Bronxville, New York, become the 77th president of ACOG and the first Black woman to hold the position, and a day 3 keynote address from former First Lady Michelle Obama, ACOG75 had no shortage of excitement.

Take a look below at our published coverage of the meeting so far. In the coming days, our expert interviews and abstract coverage will continue, so be sure to visit this link for the latest out of the meeting.

Before we get into our coverage published so far, learn more about the new president of ACOG below.

Camille A. Clare, president of ACOG

Clare is a practicing obstetrician-gynecologist (ob-gyn) and a professor at the Albert Einstein College of Medicine. Her previous leadership roles include serving as chair and tenured professor at the Downstate Health Sciences University College of Medicine and associate dean of diversity and inclusion at New York Medical College, according to an announcement from ACOG.²

In her inaugural address, Clare focused on the concept of legacy and the responsibility of physician leadership. She encouraged engagement among younger physicians, emphasizing that leadership is practiced through daily advocacy and ensuring scientific advancements reach all communities.

“Legacy is something each of us creates every day. It is the impact we have on our patients, the knowledge we share with our learners, the science we advance, and the voices we raise,” said Clare. “As the first Black woman president of ACOG, I am deeply aware of the moments, mentors, and support that carried me to where I am today, and of what this moment represents for those who are watching and wondering whether they too can lead.

“Leadership means listening. Leadership means advocating. Leadership means ensuring that the science we advance reaches every patient and every community.… Leadership is never practiced in the abstract: It is shaped by who we are, where we have come from, and the responsibility we inherit,” added Clare.

Recapping Contemporary OB/GYN at ACOG

Julie Anderson on the impact of virtual birth planning for high-risk pregnancies

Julie Anderson presented data demonstrating that virtual birth planning is associated with a nearly 4-fold increase in shared decision-making for high-risk patients.

Click here to watch.

Inclusive gynecologic care for LGBTQ patients starts at the front desk

Creating a genuinely welcoming clinical environment for LGBTQ patients begins well before the exam room—and the most meaningful changes are often also the simplest, according to Kathleen S. Walsh, MD, FACOG, an ob-gyn with Hackensack Meridian Health.
Click here to watch.

Pelin Batur, MD, on navigating sexual health concerns and HSDD throughout the life continuum

Pelin Batur, MD, emphasizes that half of patients are unsatisfied with their sexual health and clinicians should normalize these concerns through simple, open-ended questions.

“Even asking without the promise of addressing it right then can help establish a safe space for patients to bring it up,” Batur explained. If a patient appears hesitant, Batur suggests normalizing the concern by stating, “Many patients have concerns about sexual functioning. How about you?” followed by an invitation for the patient to share their experience.

Click here to watch.

Hormone therapy, neurokinin antagonists, and the evolving menopause treatment landscape

Clinicians managing vasomotor symptoms now have a broader and more effective toolkit than ever before. However, translating that into individualized treatment decisions requires time, a thorough history, and a clear understanding of which contraindications to hormone therapy are real and which are not, according to Jill Liss, MD, MSCP, FACOG, an associate clinical professor of obstetrics and gynecology at the University of Colorado School of Medicine.

Click here to watch.

How patients are responding to elinzanetant, with Genevieve Neal-Perry, MD, PhD

Since its approval, how have patients been responding to elinzanetant? Genevieve Neal-Perry, MD, PhD, of the University of North Carolina School of Medicine, Chapel Hill, answers that question and many more at the link below.

Click here to watch.

Molly Dickinson, DO, on the rare repair of a 22-week uterine rupture with placenta accreta

Molly Dickinson, DO, Jefferson Einstein Philadelphia Hospital, presented a unique case report of a successful repair of a 22-week rupture, allowing for the delivery of a healthy infant at 32 weeks. The case was further complicated by placenta accreta, identified via MRI at 24 weeks and confirmed upon delivery.

Click here to watch.

References

1. ACOG. Contemporary OB/GYN. Accessed May 5, 2026. https://www.contemporaryobgyn.net/conferences/acog
2. ACOG inaugurates Camille A. Clare MD, MPH, CPE, FACOG, as 77th president at 2026 Annual Clinical & Scientific Meeting. News release. American College of Obstetricians & Gynecologists. May 3, 2026. Accessed May 6, 2026. https://www.acog.org/news/news-releases/2026/05/acog-inaugurates-camille-clare-as-77th-president-at-2026-acsm